A public health ethics analysis of Doxy-PEP: arguments for and against – the ‘yes’ case
Sam Templeman B and Bridget Haire
A *
A
B
Abstract
In September 2023, the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine recommended consideration of doxycycline post-exposure prophylaxis to prevent STIs in gay, bisexual and other men who have sex with men. On 6 June 2024, the US Centers for Disease Control and Prevention added the intervention to its clinical guidelines. However, expanding antibiotic use carries the risk of propagating antimicrobial resistance among target STIs and non-target pathogens, prompting some experts to advocate withholding doxycycline post-exposure prophylaxis until further research is done. Thus, the use of doxycycline post-exposure prophylaxis is a question of whether the risk of antimicrobial resistance to the population is justified by the health benefits to gay, bisexual and other men who have sex with men. Here, we outline the public health ethics cases for and against this strategy.
Keywords: antimicrobial resistance, bacterial STIs, Doxy PEP, doxycycline PEP, gay and bisexual men, men who have sex with men, public health ethics, STI prevention, syphilis.
References
1 Wald A. Global resurgence of syphilis (Including Congenital Syphilis). NEJM J Watch 2023; NA56359.
| Crossref | Google Scholar |
2 King J, McManus H, Kwon A, Gray R, McGregor S. HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2022. Sydney: UNSW; 2022. Available at https://www.kirby.unsw.edu.au/sites/default/files/documents/Annual-Surveillance-Report-2022_STI.pdf [cited 22 October 2023]
3 Wilkinson AL, Scott N, Tidhar T, Luong P, El-Hayek C, Wilson DP, et al. Estimating the syphilis epidemic among gay, bisexual and other men who have sex with men in Australia following changes in HIV care and prevention. Sex Health 2019; 16(3): 254-62.
| Crossref | Google Scholar |
4 Kass NE. An ethics framework for public health. Am J Public Health 2001; 91(11): 1776-82.
| Crossref | Google Scholar |
5 Cornelisse V, Riley B, Medland N, Round Table Participants. 2023 Consensus Statement on doxycycline prophylaxis (Doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual, and other men who have sex with men in Australia; 2023. Available at https://ashm.org.au/about/news/doxy-pep-statement
6 Fredericksen RJ, Perkins R, Brown CE, Cannon C, Lopez C, Cohee A, et al. Doxycycline as postsexual exposure prophylaxis: use, acceptability, and associated sexual health behaviors among a multi-site sample of clinical trial participants. AIDS Patient Care STDS 2024; 38(4): 155-67.
| Crossref | Google Scholar |
7 Luetkemeyer AF, Donnell D, Dombrowski JC, Cohen S, Grabow C, Brown CE, et al. Postexposure doxycycline to prevent bacterial sexually transmitted infections. N Engl J Med 2023; 388(14): 1296-306.
| Crossref | Google Scholar |
8 Molina J-M, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis 2018; 18(3): 308-17.
| Crossref | Google Scholar |
9 Molina JM, Bercot B, Assoumou L, et al. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design. Lancet Infect Dis 2024; 24(10): 1093-104.
| Google Scholar |
10 Wilson DP, Prestage GP, Gray RT, Hoare A, McCann P, Down I, et al. Chemoprophylaxis is likely to be acceptable and could mitigate syphilis epidemics among populations of gay men. Sex Transm Dis 2011; 38(7): 573-9.
| Crossref | Google Scholar |
11 World Health Organization. Syphilis; 2024. Available at https://www.who.int/news-room/fact-sheets/detail/syphilis#:~:text=Syphilis%20is%20a%20preventable%20and,pregnancy%20and%20through%20blood%20transfusion
12 Stewart J, Oware K, Donnell D, Violette LR, Odoyo J, Soge OO, et al. Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women. N Engl J Med 2023; 389(25): 2331-40.
| Crossref | Google Scholar |
13 Chu VT, Glascock A, Donnell D, Grabow C, Brown CE, Ward R, Love C, Kalantar KL, Cohen SE, Cannon C, Woodworth MH, Kelley CF, Celum C, Luetkemeyer AF, Langelier CR. Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome. Nat Med 2025; 31(1): 207-7.
| Crossref | Google Scholar | PubMed |
14 Cornelisse VJ, Ong JJ, Ryder N, Ooi C, Wong A, Kenchington P, et al. Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand – the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Sex Health 2023; 20(2): 99-104.
| Crossref | Google Scholar |
15 Peyriere H, Makinson A, Marchandin H, Reynes J. Doxycycline in the management of sexually transmitted infections. J Antimicrob Chemother 2017; 73(3): 553-63.
| Crossref | Google Scholar |
16 Kenyon C, Gestels Z, Vanbaelen T, Abdellati S, Van Den Bossche D, De Baetselier I, et al. Doxycycline PEP can induce doxycycline resistance in Klebsiella pneumoniae in a Galleria mellonella model of PEP. Front Microbiol 2023; 14: 1208014.
| Crossref | Google Scholar |
17 Bellefleur O, Keeling M. Utilitarianism in public health. National Collaborating Centre for Healthy Public Policy; 2016. Available at http://www.ncchpp.ca/docs/2016_Ethics_Utilitarianism_En.pdf [cited 22 October 2023]
19 Taouk ML, Taiaroa G, Pasricha S, Herman S, Chow EPF, Azzatto F, et al. Characterisation of Treponema pallidum lineages within the contemporary syphilis outbreak in Australia: a genomic epidemiological analysis. Lancet Microbe 2022; 3(6): e417-e26.
| Crossref | Google Scholar | PubMed |
20 Williamson DA, Chow EPF, Gorrie CL, Seemann T, Ingle DJ, Higgins N, et al. Bridging of Neisseria gonorrhoeae lineages across sexual networks in the HIV pre-exposure prophylaxis era. Nat Commun 2019; 10(1): 3988.
| Crossref | Google Scholar |
21 Jamrozik E, Heriot GS. Ethics and antibiotic resistance. Br Med Bull 2022; 141(1): 4-14.
| Crossref | Google Scholar |
22 Traeger M, Stoové M. Why risk matters for STI control: who are those at greatest risk and how are they identified? Sex Health 2022; 19(4): 265-77.
| Crossref | Google Scholar |
23 Chan C, Mao L, Bavinton BR, Holt M, Prankumar SK, Dong K, et al. The impact of social connections and discrimination to HIV risk among Asian gay and bisexual men in Australia. Sex Health 2023; 20: 479-87.
| Crossref | Google Scholar |
24 European Parliament. The precautionary principle: definitions, applications and governance; 2015. Available at https://www.europarl.europa.eu/thinktank/en/document/EPRS_IDA(2015)573876 [cited 22 October 2023]
